Getting your Trinity Audio player ready...

Recently, several companies have disclosed their financial results, attracting investor attention. According to “The Street Experts”, investors should consider monitoring the following three stocks: Faraday Future Intelligent Electric Inc. (NASDAQ: FFIE), Plug Power Inc. (NASDAQ: PLUG), and SunPower Corporation (NASDAQ: SPWR). Four additional stocks are discussed in this news article.

Catheter Precision Inc. (NYSE American: VTAK): Known for its expertise in cardiac electrophysiology, the company disclosed its Q1 2024 financial results on May 6. Earnings reflected a narrower-than-anticipated loss at 36 cents per share, surpassing the forecasted 42 cents. During this quarter, Catheter Precision reported revenue of $820,000, with total assets valued at $28 million. At the close of the quarter, shareholder equity was reported at $18.5 million. Additionally, Catheter Precision recently secured new purchase orders from Ronald Reagan UCLA Medical Center Rady Children’s Hospital (UCLA), University of California San Diego Health System (UCSD) and HCA Healthcare Inc. (NYSE: HCA). 

Intelligent Bio Solutions (NASDAQ: INBS) On May 9, disclosed its financial performance for Q3 of fiscal year 2024. The company reported a loss of $1.43 per share, which was notably better than analysts’ expectations of a $2.52 loss per share. However, the reported revenue of $823,800 for the quarter fell short of the projected $1.08 million. The company highlighted its revenue growth during the quarter, attributing it to the acquisition of 26 new accounts and a consistent expansion in its installed base. 

Peraso Inc. (NASDAQ: PRSO), recognized as a leading authority in mmWave technology for 60 GHz 5G networks, both unlicensed and licensed, which are integrated into Panasonic Corporation’s (Tokyo: 6752.T) (OTC: PCRFF) systems across Japan, announced its fiscal Q1 2024 financial outcomes on May 13. The company reported a net revenue of $2.8 million for the quarter, marking a significant increase from the $1.8 million recorded in the previous quarter and surpassing Wall Street expectations. 

Dyadic International Inc. (NASDAQ: DYAI), a biotechnology firm engaged in large-scale protein production for use in human and animal vaccines and therapeutics, disclosed its financial outcomes for Q1 2024 on May 14. At the quarter’s conclusion, Dyadic International reported having $12.1 million in cash, cash equivalents, and securities, an increase from $7.3 million as of December 31, 2023. The company recorded revenues of $335,000 for the quarter, a decrease from the $934,000 reported in the same period the previous year. The company emphasized its ongoing efforts to implement its business strategy during the quarter.

2024 Strategy to enter the food and beverage industry, aiming to effectively cater to the growing demand for “Future of Foods.”